Categories for Research

Blog

One contraceptive for both men and women
YourChoice Therapeutics is attempting to revolutionize birth control options for women and men by developing options that are hormone-free, safe, easy to use, and effective. In men, the product disables the flagellated tail, inhibiting sperm motility... Read full article
Blog

Contraceptive Jewelry Under Development
In the future, preventing pregnancy may be as easy as putting on jewelry. According to an article in the Journal of Controlled Release, researchers at Georgia Tech hav... Read full article
Blog

Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive? 
Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive?  Vitamin A deficient women produce less retinoic acid, ... Read full article
Blog

Report on the International Family Planning Landscape
The Center for Global Development (CGD) and Kaiser Family Foundation (KFF) held an international family planning leadership retreat from January 18-19, 2018 to discuss the current landscape of the field and approaches for moving forward. A summary Read full article
Blog

Vaginal Ring Dose-Finding Results Published
Contraceptive vaginal rings (CVRs) offer women a self-controlled, non-daily delivery system. One CVR - the FDA approved NuvaRing® - is on the market, and another, the one-year Ne... Read full article
Blog

NIH Announces Funding for Novel Contraceptive Methods
The National Institutes of Health has released a new funding solicitation to support the development of novel nonsteroidal contrac... Read full article
Blog

Contraceptive Technology Innovation: A Wise Investment
As long as some women and men find current family planning methods unacceptable, unaffordable, or inaccessible, there will be a need for contraceptive technology innovation. In the summer of 2018, Read full article
Blog

Contraceptive Technology Innovation: It’s Everyone’s Business
Guest blog contributors are Julia Bunting, OBE, President of the Population Council, and Laneta Dorflinger, PhD, Director of Contraceptive Technology Innovation at FHI 360. Their two organizations are long-time leaders in the field, bringing ... Read full article
Blog

Ferring Pharmaceuticals to Issue Biomarker Research Grants
Applications for Ferring Pharmaceuticals’ Innovation Grants Program are open until June 11th.  Non-renewable awards of $50,000 to $100,000 are available to support researc... Read full article